Back to medications
Medication monograph
axicabtagene ciloleucel
Chimeric Antigen Receptor T-Cell TherapyCAR-T Cell TherapiesCD19-directed Chimeric Antigen ReceptorGenetically-modified Autologous T CellsGene Therapy
Clinical reference
Product monograph
YESCARTA- axicabtagene ciloleucel suspension
Brands & formulations
Family members
Classification
- Chemical class
- Chimeric Antigen Receptor T-Cell Therapy
- Clinical class
- CAR-T Cell Therapies
- Banks class
- CD19-directed Chimeric Antigen Receptor, Genetically-modified Autologous T Cells
- AHFS family
- Gene Therapy